Author Correction: Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses

Nat Commun. 2023 Jul 10;14(1):4080. doi: 10.1038/s41467-023-39754-1.

Fredrika Hellgren^#^{1

2}, Alberto Cagigi^#^{1

2

3}, Rodrigo Arcoverde Cerveira^#^{1

2}, Sebastian Ols^{1

2}, Theresa Kern^{1

2}, Ang Lin^{1

2

4}, Bengt Eriksson⁵, Michael G Dodds⁶, Edith Jasny⁷, Kim Schwendt⁷, Conrad Freuling⁸, Thomas Müller⁸, Martin Corcoran⁹, Gunilla B Karlsson Hedestam⁹, Benjamin Petsch⁷, Karin Loré^{10

11}

¹ Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
² Center of Molecular Medicine, Stockholm, Sweden.
³ Nykode Therapeutics, Oslo, Norway.
⁴ School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
⁵ Astrid Fagraeus Laboratory, Comparative Medicine, Karolinska Institutet, Stockholm, Sweden.
⁶ Certara USA, Inc, Princeton, NJ, USA.
⁷ CureVac SE, Tübingen, Germany.
⁸ Institute for Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Greifswald, Germany.
⁹ Department of Microbiology and Tumor Biology, Karolinska Institutet, Stockholm, Sweden.
¹⁰ Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. karin.lore@ki.se.
¹¹ Center of Molecular Medicine, Stockholm, Sweden. karin.lore@ki.se.

^# Contributed equally.

No abstract available

Publication types